Anthropic's AI safety gate: what buyers need to check | Week in review
Send us Fan Mail
Broader AI access now comes with credentials, oversight, and a more complicated buying decision. Anthropic's Life Sciences Verification Program puts the terms of access at the center of the safety question, while Accenture's role as both evaluator and deployment partner raises questions about independence.
In this week in review, Augur examines what buyers can reasonably conclude from these arrangements, why competing security-patching percentages measure different outcomes, and what the revised selective-memory research actually establishes. The episode also separates…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.